Skip to content
Search

Latest Stories

Australia ready to host India-Pakistan series: Hockley

AUSTRALIA would be open to hosting Asian arch-rivals Pakistan and India in a series to revive a contest world cricket wants to see, board chief Nick Hockley said.

Pakistan and India's rivalry has been confined to events sanctioned by the International Cricket Council (ICC) and the Asia Cup for the best part of a decade due to the strained relations between them.


They last played a bilateral series when India hosted Pakistan for white-ball matches at the end of 2012.

Pakistan Cricket Board chairman Ramiz Raja in January proposed an annual four-nation T20 series involving Pakistan, India, Australia and England to be hosted on a rotational basis by the teams.

GettyImages 1320887159 FILE PHOTO: Nick Hockley, CEO of Cricket Australia poses for a photo at Sydney Cricket Ground on May 31, 2021 in Sydney, Australia. (Photo by Mark Evans/Getty Images)

Cricket Australia chief executive Hockley said his board had not discussed the proposal but would be open to hosting Pakistan and India in a tri-series.

"Personally, I really like the tri-series concept. It's worked well in the past," he told reporters in Rawalpindi, where Australia and Pakistan drew the first test in their three-match series.

"We'd be very open to hosting ... matches,"

"There are really big communities of both India and Pakistan living in Australia.

"It's a contest that everyone wants to see in world cricket and if we can help support further opportunities we would love to do that."

Such a series would be unlikely to happen in the short- to medium-term, with the Future Tour Programme, the ICC's international schedule, mapped out through to 2023.

Pakistan and India are scheduled to play each other at the ICC-sanctioned T20 World Cup in Australia in October.

Hockley said the Oct. 23 match at the Melbourne Cricket Ground was already sold out.

(Reuters)

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less